NCT05930093View on ClinicalTrials.gov

Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects

NARecruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

December 7, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

May 1, 2026

Conditions
NAFLD
Interventions
DIETARY_SUPPLEMENT

Placebo

Placebo matching LivPhcD cap.

DIETARY_SUPPLEMENT

2 cap.LivPhcD/per day

2 caps. LivPhcD cap. after meal, once a day

DIETARY_SUPPLEMENT

4 cap.LivPhcD/per day

4 caps. LivPhcD cap. after meal, BID

DIETARY_SUPPLEMENT

6 cap.LivPhcD/per day

6 caps. LivPhcD cap. after meal, TID

Trial Locations (1)

221

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

TCM Biotech International Corp.

INDUSTRY